PHK
LXRX icon

Point72 Hong Kong’s Lexicon Pharmaceuticals LXRX Stock Holding History

Point72 Hong Kong’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-3,603
Closed -$8K – 2215
2022
Q1 		$8K Buy
+3,603
New +$9.99K ﹤0.01% 1631
2021
Q2 		– Sell
-57
Closed – – 2176
2021
Q1 		$0 Buy
+57
New +$395 ﹤0.01% 2047
2019
Q1 		– Sell
-274
Closed -$2K – 1171
2018
Q4 		$2K Buy
+274
New +$2.22K ﹤0.01% 732
2018
Q2 		– Sell
-71
Closed -$1K – 1061
2018
Q1 		$1K Buy
+71
New +$657 ﹤0.01% 835
2017
Q4 		– Sell
-255
Closed -$3K – 984
2017
Q3 		$3K Buy
+255
New +$3.77K ﹤0.01% 616

Other funds holding LXRX

AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
PA
Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Point72 Hong Kong's LXRX Position: Q2 2022 in Review

Point72 Hong Kong sold out of Lexicon Pharmaceuticals (LXRX) in Q2 2022, closing a stake of 3,603 shares — an estimated $8K sold.

Point72 Hong Kong first reported a position in LXRX in Q3 2017 and held it in 5 quarters. The position peaked at $8K in Q1 2022. 86 funds tracked by Wall St. Rank hold LXRX as of Q2 2022.

  • Point72 Hong Kong reported no remaining Lexicon Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
  • Point72 Hong Kong sold 3,603 Lexicon Pharmaceuticals shares in Q2 2022, an estimated $8K.
  • Point72 Hong Kong first reported a position in Lexicon Pharmaceuticals in Q3 2017 and held it in 5 quarters.
  • Point72 Hong Kong's Lexicon Pharmaceuticals position peaked at $8K in Q1 2022.
  • 86 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q2 2022.

Based on Point72 Hong Kong's 13F filing for Q2 2022, filed 15 Aug 2022.